P. Clements

1.2k total citations
21 papers, 952 citations indexed

About

P. Clements is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, P. Clements has authored 21 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pathology and Forensic Medicine, 9 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in P. Clements's work include Systemic Sclerosis and Related Diseases (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). P. Clements is often cited by papers focused on Systemic Sclerosis and Related Diseases (17 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). P. Clements collaborates with scholars based in United States, Vietnam and Italy. P. Clements's co-authors include Daniel E. Furst, James R. Seibold, Paul Brennan, Peter A. Lachenbruch, A J Silman, Mary C. Massa, Virginia Steen, József Varga, Benny Zee and Dinesh Khanna and has published in prestigious journals such as Annals of the Rheumatic Diseases, British journal of surgery and Lara D. Veeken.

In The Last Decade

P. Clements

21 papers receiving 924 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Clements United States 14 712 261 242 200 173 21 952
Michael Weisman United States 6 774 1.1× 277 1.1× 189 0.8× 259 1.3× 190 1.1× 13 1.1k
Éric Rich Canada 13 749 1.1× 350 1.3× 397 1.6× 213 1.1× 308 1.8× 17 1.2k
S. Zeni Italy 16 549 0.8× 247 0.9× 277 1.1× 118 0.6× 191 1.1× 36 973
Anne A. Schouffoer Netherlands 16 559 0.8× 178 0.7× 180 0.7× 271 1.4× 94 0.5× 51 761
James V. Dunne Canada 17 550 0.8× 153 0.6× 112 0.5× 447 2.2× 207 1.2× 33 997
Benjamin Chaigne France 16 372 0.5× 86 0.3× 196 0.8× 297 1.5× 178 1.0× 52 879
Mary Carns United States 16 609 0.9× 177 0.7× 111 0.5× 298 1.5× 182 1.1× 34 923
Saskia Decuman Belgium 16 1.2k 1.6× 531 2.0× 229 0.9× 312 1.6× 318 1.8× 38 1.4k
M Matucci Cerinic Italy 17 289 0.4× 87 0.3× 256 1.1× 124 0.6× 138 0.8× 47 784
E. Genth Germany 19 449 0.6× 213 0.8× 629 2.6× 123 0.6× 397 2.3× 74 1.4k

Countries citing papers authored by P. Clements

Since Specialization
Citations

This map shows the geographic impact of P. Clements's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Clements with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Clements more than expected).

Fields of papers citing papers by P. Clements

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Clements. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Clements. The network helps show where P. Clements may publish in the future.

Co-authorship network of co-authors of P. Clements

This figure shows the co-authorship network connecting the top 25 collaborators of P. Clements. A scholar is included among the top collaborators of P. Clements based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Clements. P. Clements is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khanna, Dinesh, P. Clements, Chi‐Hong Tseng, et al.. (2016). FRI0267 Mycophenolate Mofetil versus Oral Cyclophosphamide in Scleroderma-Related Interstitial Lung Disease: Scleroderma Lung Study II. Annals of the Rheumatic Diseases. 75. 531–531. 2 indexed citations
2.
Volkmann, Elizabeth R., Donald P. Tashkin, P. Clements, et al.. (2015). SAT0444 Cyclophosphamide Versus Mycophenolate for Systemic Sclerosis-Related Interstitial Lung Disease. Annals of the Rheumatic Diseases. 74. 821–821. 2 indexed citations
3.
Furst, D.E., Sangmee Bae, P. Clements, et al.. (2014). Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards. Lara D. Veeken. 54(1). 144–151. 25 indexed citations
4.
Schiopu, Elena, Maureen McMahon, Mariana J. Kaplan, et al.. (2013). Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Lara D. Veeken. 53(4). 704–713. 36 indexed citations
5.
6.
Khanna, Dinesh, Paul Maranian, Nan Rothrock, et al.. (2011). Feasibility and Construct Validity of PROMIS and “Legacy” Instruments in an Academic Scleroderma Clinic. Value in Health. 15(1). 128–134. 61 indexed citations
7.
Frech, Tracy, Ron D. Hays, Paul Maranian, et al.. (2011). Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study. Lara D. Veeken. 50(7). 1280–1287. 44 indexed citations
8.
Khanna, Puja, D E Furst, P. Clements, et al.. (2010). Gender and ethnicity differences in patients with diffuse systemic sclerosis--analysis from three large randomized clinical trials. Lara D. Veeken. 50(2). 335–342. 21 indexed citations
9.
Weng, Hsu‐Huei, Veena K. Ranganath, M. Oh, et al.. (2010). Differences in presentation of younger and older systemic sclerosis patients in clinical trials.. PubMed. 28(5 Suppl 62). S10–4. 5 indexed citations
10.
11.
Clements, P., Michael D. Roth, Robert M. Elashoff, et al.. (2007). Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis. Annals of the Rheumatic Diseases. 66(12). 1641–1647. 60 indexed citations
12.
Clements, P., et al.. (2003). Assessment of gastrointestinal involvement.. PubMed. 21(3 Suppl 29). S15–8. 71 indexed citations
13.
Law, Nancy, et al.. (2000). Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.. PubMed. 27(5). 1156–63. 60 indexed citations
14.
Wong, Andrew L., Wai Keong Wong, Judith O. Harker, et al.. (1999). Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.. PubMed. 26(12). 2551–61. 42 indexed citations
15.
Furst, Daniel E. & P. Clements. (1997). Hypothesis for the pathogenesis of systemic sclerosis.. PubMed. 48. 53–7. 65 indexed citations
16.
Clements, P., Peter A. Lachenbruch, James R. Seibold, et al.. (1993). Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.. PubMed. 20(11). 1892–6. 378 indexed citations
17.
Clements, P.. (1992). Clinical aspects of localized and systemic sclerosis.. PubMed. 4(6). 843–50. 7 indexed citations
18.
Furst, Daniel E., et al.. (1984). Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration.. Annals of the Rheumatic Diseases. 43(6). 794–801. 26 indexed citations
19.
Hedley, A. J., P. D. Bewsher, S J Jones, et al.. (1983). Late onset hypothyroidism after subtotal thyroidectomy for hyperthyroidism: Implications for long term follow-up. British journal of surgery. 70(12). 740–743. 25 indexed citations
20.
Swezey, Robert L., et al.. (1979). Arthritic hand response to pressure gradient gloves.. PubMed. 60(8). 375–7. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Weisman Breakdown of academic impact, for papers by Éric Rich Breakdown of academic impact, for papers by S. Zeni Breakdown of academic impact, for papers by Anne A. Schouffoer Breakdown of academic impact, for papers by James V. Dunne Breakdown of academic impact, for papers by Benjamin Chaigne Breakdown of academic impact, for papers by Mary Carns Breakdown of academic impact, for papers by Saskia Decuman Breakdown of academic impact, for papers by M Matucci Cerinic Breakdown of academic impact, for papers by E. Genth
Rankless by CCL
2026